Position in MRNA
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$210,090
+$9,600 QoQ
Shares Held
3,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#498
of 772 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FOUNDERS CAPITAL MANAGEMENT, LLC holds $5,438,472 across 2 Biotechnology names. MRNA ranks #2 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,385 | $5,228,382 | |
| 2 | MRNA |
Moderna, Inc.
This page
|
3,000 | $210,090 |
All Filings in MRNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $210,090 | 3,000 | Shares | Sole | 2026-07-20 | |
| 2024-09-30 | $200,490 | 3,000 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $356,250 | 3,000 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $321,811 | 3,020 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $300,339 | 3,020 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $311,935 | 3,020 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $366,930 | 3,020 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $463,811 | 3,020 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $542,452 | 3,020 | Shares | Sole | 2023-01-20 | |
| No filing history on record for this holder in this stock. | ||||||